Regulation of B‐cell function and expression of CD11c, T‐bet, and FcRL5 in response to different activation signals
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350736 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Linn Kleberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: T-Box Domain Proteins, CD11c Antigen, B-Lymphocytes, Toll-Like Receptor 9. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stockholm läns landsting, Magnus Bergvalls Stiftelse, Karolinska Institutet.
Abstract (Originalsprache)
CD11c, FcRL5, or T‐bet are commonly expressed by B cells expanding during inflammation, where they can make up >30% of mature B cells. However, the association between the proteins and differentiation and function in the host response remains largely unclear. We have assessed the co‐expression of CD11c, T‐bet, and FcRL5 in an in vitro B‐cell culture system to determine how stimulation via the BCR, toll‐like receptor 9 (TLR9), and different cytokines influence CD11c, T‐bet, and FcRL5 expression. We observed different expression dynamics for all markers, but a largely overlapping regulation of CD11c and FcRL5 in response to BCR and TLR9 activation, while T‐bet was strongly dependent on IFN‐γ signaling. Investigating plasma cell differentiation and APC functions, there was no association between marker expression and antibody secretion or T‐cell help. Rather the functions were associated with TLR9‐signalling and B‐cell‐derived IL‐6 production, respectively. These results suggest that the expression of CD11c, FcRL5, and T‐bet and plasma cell differentiation and improved APC functions occur in parallel and are regulated by similar activation signals, but they are not interdependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
- Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Christopher Sundling
Förderung
- Stockholm läns landsting
- Magnus Bergvalls Stiftelse
- Karolinska Institutet
- Åke Wiberg Stiftelse
- Vetenskapsrådet
Zitieren
APA
Kleberg, L., Courey-Ghaouzi, A. D., Lautenbach, M. J., Färnert, A., & Sundling, C. (2024). Regulation of B‐cell function and expression of CD11c, T‐bet, and FcRL5 in response to different activation signals. European Journal of Immunology. https://doi.org/10.1002/eji.202350736
Vancouver
Kleberg L, Courey-Ghaouzi AD, Lautenbach MJ, Färnert A, Sundling C. Regulation of B‐cell function and expression of CD11c, T‐bet, and FcRL5 in response to different activation signals. European Journal of Immunology. 2024. doi:10.1002/eji.202350736
BibTeX
@article{Kleberg2024,
author = {Kleberg, Linn and Courey-Ghaouzi, Alan-Dine and Lautenbach, Maximilian Julius and Färnert, Anna and Sundling, Christopher},
title = {Regulation of B‐cell function and expression of CD11c, T‐bet, and FcRL5 in response to different activation signals},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350736}
}
EUVIMED